Scandinavian ChemoTech is a R&D oriented publicly listed Life Science company with more than 30 years of collected research and intellectual properties in the field of electroporation and clinical research, ChemoTech has developed a new patented Tumour Specific Electroporation™ platform. A technology platform, called IQwave™, specifically designed to treat patients with larger bulk tumours that are difficult to treat with traditional cancer therapies.
